Moreover, BGN expression has potential usefulness for the development of ST-EPN therapy because inhibition of renal cell carcinoma growth has been promoted by biglycan siRNA-containing nanodevices in vivo models [22]. The gene discussed is BGN; the disease is renal cell carcinoma.